Double blind placebo controlled dose ranging study of the efficacy and safety of SSR149744c [celivarone] 100 or 300mg for the prevention of ventricular arrhythmia-triggered ICD interventions.
Latest Information Update: 14 May 2012
At a glance
- Drugs Celivarone (Primary)
- Indications Ventricular arrhythmias
- Focus Adverse reactions; Therapeutic Use
- Acronyms ICARIOS
- Sponsors Sanofi
- 07 Jul 2009 Actual patient number (153) added as reported by ClinicalTrials.gov
- 02 Aug 2007 Status changed from in progress to completed.
- 05 Oct 2006 Status change